background
despit
pauciti
clinic
evid
hydroxychloroquin
azithromycin
administ
wide
patient
verifi
suspect
drug
may
increas
risk
lethal
arrhythmia
associ
qt
interv
prolong
method
perform
case
seri
positivesuspect
patient
admit
treat
azithromycin
hydroxychloroquin
combin
evalu
baselin
postmed
qt
interv
qtc
bazett
use
ecg
critic
qtc
prolong
defin
maximum
qtc
ms
qr
ms
qtc
qr
ms
b
increas
qtc
ms
tisdal
score
elixhaus
comorbid
index
calcul
result
positivesuspect
patient
receiv
eitherboth
drug
posit
suspect
met
studi
criteria
age
yr
male
azithromycin
prescrib
hydroxychloroquin
baselin
mean
qtc
ms
increas
medic
signific
prolong
observ
men
ms
vs
ms
women
patient
reach
critic
qtc
prolong
multivari
logist
regress
age
sex
tisdal
score
elixhaus
score
baselin
qtc
associ
critic
qtc
prolong
p
chang
qtc
highest
combin
compar
either
drug
manyfold
greater
prolong
combin
vs
azithromycin
alon
vs
ms
patient
manifest
torsad
de
point
ongo
pandem
unpreced
public
health
challeng
global
level
april
american
test
posit
patient
succumb
ill
absenc
vaccin
proven
therapeut
agent
hydroxychloroquin
hcq
azithromycin
az
often
use
combin
emerg
potenti
therapi
base
extrem
hcq
antimalari
drug
also
use
treat
arthriti
system
lupu
erythematosu
az
macrolid
antibiot
use
treat
wide
varieti
bacteri
infect
drug
prolong
qt
interv
block
cardiac
potassium
channel
therebi
increas
risk
torsad
de
point
gener
hcq
reason
welltoler
use
chronic
arthriti
sle
patient
without
heart
rhythm
monitor
fda
issu
black
warn
az
follow
multipl
report
case
qtc
prolong
follow
torsad
de
point
sinc
use
drug
patient
recent
base
larg
vitro
studi
anecdot
observ
commun
prescrib
practic
asyet
unclear
importantli
inform
avail
regard
extent
qtc
prolong
combin
hcq
az
first
principl
simultan
block
cardiac
potassium
channel
agent
may
caus
critic
qtc
prolong
elev
risk
torsad
de
point
therefor
evalu
prescrib
practic
monitor
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
qtc
interv
posit
suspect
patient
receiv
medic
studi
approv
cedarssinai
institut
review
board
identifi
patient
confirm
infect
well
patient
investig
pui
admit
cedarssinai
medic
center
lo
angel
california
receiv
either
az
andor
hcq
part
medic
treatment
detail
retrospect
chart
review
perform
via
electron
health
record
epic
verona
wi
institut
pui
confirm
case
includ
patient
least
two
electrocardiogram
ecg
perform
muse
system
patient
pace
ventricular
rhythm
atrial
fibril
atrial
flutter
supraventricular
tachycardia
ecg
otherwis
unsuit
accur
qt
interv
measur
exclud
addit
patient
without
ecg
perform
day
medic
administr
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
compar
obtain
standard
ecg
paramet
includ
correct
qt
interv
qtc
bazett
formula
baselin
ecg
closest
prior
medic
administr
longest
qtc
observ
postmed
administr
hour
last
medic
dose
given
variabl
heart
rate
qtc
prolong
also
evalu
use
fridericia
formula
correct
qt
interv
qt
measur
independ
review
valid
cardiologist
ensur
accuraci
automat
measur
manual
measur
need
patient
assign
one
three
group
depend
medic
receiv
az
hcq
az
hcq
patient
demograph
clinic
histori
lab
medic
obtain
detail
chart
review
includ
risk
factor
calcul
tisdal
score
elixhaus
comorbid
index
patient
tisdal
score
consist
age
yr
femal
sex
use
loop
diuret
potassium
level
meql
baselin
qtc
ms
acut
mi
number
qt
prolong
medic
sepsi
heart
failur
develop
risk
score
qtc
interv
prolong
elixhaus
comorbid
index
incorpor
differ
variabl
includ
obes
diabet
peripher
arteri
diseas
chronic
kidney
diseas
hiv
cancer
use
predict
inhospit
mortal
outcom
interest
baselin
qtc
ms
postmed
critic
qtc
prolong
defin
follow
maximum
postmed
qtc
ms
qr
ms
qtc
qr
ms
b
mean
increas
baselin
qtc
maximum
postmed
qtc
ms
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
statist
analysi
evalu
mean
chang
baselin
qtc
longest
qtc
overal
medic
type
use
repeat
measur
analysi
varianc
also
evalu
frequenc
critic
ecg
chang
overal
medic
type
patient
characterist
use
chisquar
analys
given
rel
low
number
patient
receiv
hcq
alon
decis
made
compar
az
combin
az
hcq
use
multivari
logist
regress
evalu
whether
age
sex
tisdal
score
elixhaus
score
baselin
qtc
associ
critic
qtc
prolong
total
patient
admit
medic
center
verifi
suspect
diagnosi
studi
time
period
treat
az
hcq
combin
patient
ecg
perform
treatment
subgroup
confirm
covid
infect
pui
age
yr
male
met
criteria
inclus
studi
tabl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
qtc
baselin
like
start
combin
two
medic
contrast
patient
higher
baselin
qtc
like
receiv
either
hcq
az
rather
combin
mean
chang
qtc
valu
greatest
combin
hcq
az
group
compar
az
group
qtc
prolong
due
combin
observ
severalfold
higher
due
az
alon
ms
vs
ms
tabl
signific
differ
regard
age
sex
sepsi
tabl
patient
critic
qtc
prolong
high
tisdal
score
wherea
patient
without
critic
qtc
chang
high
tisdal
score
similarli
signific
differ
elixhaus
comorbid
indic
two
group
multivari
logist
regress
none
follow
predictor
significantli
associ
critic
qtc
prolong
age
sex
tisdal
score
elixhaus
score
baselin
qtc
p
patient
syncop
torsad
de
point
lethal
arrhythmia
drug
administr
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
singl
larg
commun
medic
center
studi
posit
suspect
patient
hcq
az
administ
either
individu
combin
although
lethal
arrhythmia
observ
limit
period
observ
patient
attain
critic
qtc
prolong
qtc
prolong
manyfold
higher
hcq
az
administ
combin
compar
az
alon
moreov
patient
achiev
critic
qtc
prolong
distinguish
significantli
higher
tisdal
score
higher
elixhaus
comorbid
indic
find
greatest
qtc
prolong
combin
hcq
az
group
import
studi
patient
lower
valu
qtc
baselin
like
start
combin
two
medic
contrast
patient
higher
baselin
qtc
like
receiv
either
hcq
az
rather
combin
suggest
prescript
practic
may
driven
concern
regard
excess
qtc
prolong
use
medic
combin
review
data
show
practition
decid
stagger
dose
regimen
one
drug
follow
drug
later
hospit
stay
howev
given
prolong
halfliv
medic
practic
still
result
combin
drug
effect
qtc
anoth
interest
find
studi
men
significantli
higher
rate
qtc
prolong
women
incid
torsad
de
point
known
higher
women
femal
sex
risk
factor
tisdal
score
qt
prolong
reason
discrep
still
need
explain
could
relat
major
patient
popul
men
sinc
rate
high
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
sex
find
explain
differ
overal
morbid
burden
would
benefit
studi
overal
find
support
need
monitor
qtc
period
two
medic
administ
especi
use
combin
abl
distinguish
patient
like
critic
qtc
prolong
tisdal
score
elixhaus
index
make
monitor
medic
administr
like
safer
approach
addit
qtc
prolong
result
variat
dose
pattern
durat
treatment
medic
import
note
potenti
influenc
ecg
longest
qtc
may
observ
due
inconsist
obtain
daili
ecg
medic
administr
believ
patient
experienc
critic
qtc
prolong
like
underestim
furthermor
variabl
heart
rate
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
especi
set
sepsi
affect
qt
interv
correct
report
qtc
use
bazett
correct
consist
major
publish
literatur
well
ecg
record
machin
typic
use
rel
small
sampl
size
allow
assess
torsad
de
point
risk
agent
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
